You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pheochromocytoma

Showing 1 - 25 of 166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intraoperative Hemodynamic Instability During Unilateral

Recruiting
  • Pheochromocytoma
  • Non-Secretory Adrenal Adenoma
  • adrenalectomy
  • Nancy, France
    CHRU Nancy - Département Chirurgie Viscérale, Métabolique et Can
Sep 25, 2023

Adrenal Pheochromocytoma, Hemodynamic Trial (Abandonment of intravenous volume expansion during preoperative preparation in

Completed
  • Adrenal Pheochromocytoma
  • Hemodynamic
  • Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma
  • (no location specified)
Mar 25, 2023

Anlotinib Treatment Response Using Contrast Enhanced Ultrasound

Recruiting
  • Pheochromocytoma, Metastatic
  • +3 more
  • Contrast-enhanced ultrasound(CEUS)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 28, 2023

Pheochromocytoma, Metastatic, Paraganglioma, Malignant, Pheochromocytoma Malignant Trial in Beijing (Temozolomide capsule)

Completed
  • Pheochromocytoma, Metastatic
  • +2 more
  • Temozolomide capsule
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 4, 2023

Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)

Recruiting
  • Pheochromocytoma, Metastatic
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 31, 2023

Pheochromocytoma, Endocrine Disease, Endocrine Diseases Trial run by the Eunice Kennedy Shriver National Institute of Child

Recruiting
  • Pheochromocytoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 18, 2023

Pheochromocytoma, Paraganglioma Trial in Beijing (Temozolomide)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Pheochromocytoma, Paraganglioma Trial in Beijing (Anlotinib HCl)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Anlotinib hydrochloride
  • Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT

Terminated
  • Pheochromocytoma
  • Paraganglioma
  • F-18 FDOPA PET/CT
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 13, 2023

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

PGL Trial in Beijing

Recruiting
  • PGL
    • Beijing, Beijing, China
      Peking Union Medical College Hospital,Chinese Academy of Medical
    Mar 6, 2023

    Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))

    Not yet recruiting
    • Pheochromocytoma
    • Paraganglioma
    • [18F]FluorThanatrace ([18F]FTT)
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Dec 1, 2022

    Paraganglioma, Pheochromocytoma Trial in New York, Cleveland (Lanreotide)

    Recruiting
    • Paraganglioma
    • Pheochromocytoma
    • New York, New York
    • +1 more
    Oct 5, 2022

    Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)

    Recruiting
    • Pheochromocytoma
    • Paraganglioma
    • New York, New York
      Columbia University Irving Medical Center
    Oct 5, 2022

    Pheochromocytoma, Paraganglioma, Adrenalectomy; Status Trial in Seoul (Phenoxybenzamine)

    Recruiting
    • Pheochromocytoma
    • +3 more
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jan 18, 2023

    Pheochromocytoma Trial in Seoul (dexmedetomidine, 0.9% normal saline)

    Completed
    • Pheochromocytoma
    • Seoul, Korea, Republic of
      Severance hospital
    Sep 12, 2023

    Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in Rochester

    Completed
    Has Results
    • Malignant Adrenal Gland Pheochromocytoma
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Sep 28, 2022

    Dysglycemia in Pheochromocytoma and Paraganglioma

    Active, not recruiting
    • Pheochromocytoma
    • Paraganglioma
    • Catecholamines
    • Beijing, Beijing, China
      Xian-Liang Zhou
    Jul 9, 2022

    Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +2 more
    • (no location specified)
    Sep 13, 2023

    Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Pheochromocytoma, Metastatic Trial in Beijing (anlotinib HCl)

    Recruiting
    • Malignant Adrenal Gland Pheochromocytoma
    • +4 more
    • anlotinib hydrochloride
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 26, 2022

    Neuroblastoma, Pheochromocytoma Trial in Memphis (18F-DA)

    Recruiting
    • Neuroblastoma
    • Pheochromocytoma
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Feb 15, 2022

    I Hemodynamic Instability and Conversion in Adrenalectomy for

    Completed
    • adrenalDisease
    • laparoscopic adrenalectomy
    • (no location specified)
    Sep 26, 2023

    Neuroblastoma, Pheochromocytoma Trial in New Hyde Park (131-I-meta-iodobenzylguanidine)

    Available
    • Neuroblastoma
    • Pheochromocytoma
    • New Hyde Park, New York
      Cohen Children's Medical Center
    Apr 4, 2022

    Pheochromocytoma, Paraganglioma, Cardiovascular Morbidity Trial in Lucknow (Observational study)

    Completed
    • Pheochromocytoma
    • +2 more
    • Observational study
    • Lucknow, Uttar Pradesh, India
      Sanjay Gandhi Postgraduate Institute of Medical Sciences
    Feb 9, 2022

    Pheochromocytoma, Paraganglioma Trial in Marseille (Infrared themrography)

    Recruiting
    • Pheochromocytoma
    • Paraganglioma
    • Infrared themrography
    • Marseille, Paca, France
      Pôle ENDO- Hopital la Conception APHM
    Nov 12, 2022